Breast cancer
This study aimed to facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes.
Investigation of the biological origins of coordinately expressed genes in breast cancer could clarify the relationship between prognostic gene signatures and tumor pathobiology.
This dataset consists of breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore). The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.
--
--
Breast tumor samples were profiled on the Affymetrix U133A platform.
Nagalla, Srikanth, Jeff W. Chou, Mark C. Willingham, Jimmy Ruiz, James P. Vaughn, Purnima Dubey, Timothy L. Lash, et al. “Interactions between Immunity, Proliferation and Molecular Subtype in Breast Cancer Prognosis.” Genome Biology 14, no. 4 (April 29, 2013): R34. doi:10.1186/gb-2013-14-4-r34.
Sample ID | series | IMS | IBS | IDS | ICR |
---|---|---|---|---|---|
GSM1100037 | NA | LumA | IBD | WID | ICR4 |
GSM1100038 | NA | LumB | IBE | WID | ICR3 |
GSM1100039 | NA | Normal | IBE | NA | ICR1 |
GSM1100040 | NA | LumA | IBD | PID | ICR1 |
GSM1100041 | NA | LumA | IBD | PID | ICR2 |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Series | IMS | IBS | IDS | ICR | HER2 Status | Array Sample ID | Sample Title | DMFS 10Y EVENT | DMFS 10Y TIME | Disease Free Survival Event | Distant Met Free Survival Event | Age At Initial Pathologic Diagnosis | Lymph Node Status | ER Status | PR Status | Histology Differentiation Grade | Tumor Size Cm | Pathology T Stage | Disease Free Survival Years | Distant Met Free Survival Years | Disease Specific Survival Years | Treatment Adjuvant | Characteristics Endocrine? | Chemo? | Breast Cancer Cause Of Death | Histologic Diagnosis | Type Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSM1100037 | NA |
LumA |
IBD |
WID |
ICR4 |
HER2- |
400003289 |
NUH.BT009 |
DistantMetastasisFree |
6.17 |
DiseaseFree |
DistantMetastasisFree |
41 |
LN- |
ER+ |
PR+ |
G2 |
2 |
T1c |
6.17 |
6.17 |
6.17 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100038 | NA |
LumB |
IBE |
WID |
ICR3 |
HER2+ |
400003290 |
NUH.BT014 |
DistantMetastasis |
1.13 |
Recurred/Progressed |
DistantMetastasis |
62 |
LN+ |
ER- |
PR- |
G2 |
3 |
T2 |
1.13 |
1.13 |
1.13 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100039 | NA |
Normal |
IBE |
NA |
ICR1 |
HER2- |
400003291 |
NUH.BT018 |
DistantMetastasisFree |
4.29 |
DiseaseFree |
DistantMetastasisFree |
69 |
LN- |
ER+ |
PR+ |
G2 |
3 |
T2 |
4.29 |
4.29 |
4.29 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100040 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2- |
400003292 |
NUH.BT019 |
DistantMetastasisFree |
5.88 |
DiseaseFree |
DistantMetastasisFree |
69 |
LN- |
ER+ |
PR+ |
G2 |
3.5 |
T2 |
5.88 |
5.88 |
6.04 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100041 | NA |
LumA |
IBD |
PID |
ICR2 |
HER2+ |
400003293 |
NUH.BT022 |
DistantMetastasisFree |
2.63 |
DiseaseFree |
DistantMetastasisFree |
40 |
LN- |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
2.63 |
2.63 |
2.63 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100042 | NA |
Normal |
IBE |
NA |
ICR2 |
HER2+ |
400003294 |
NUH.BT023 |
DistantMetastasisFree |
6.25 |
DiseaseFree |
DistantMetastasisFree |
69 |
LN- |
ER+ |
PR- |
G2 |
2.5 |
T2 |
6.25 |
6.25 |
6.25 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100043 | NA |
LumB |
IBD |
WID |
ICR3 |
HER2+ |
400003295 |
NUH.BT029 |
DistantMetastasis |
2 |
Recurred/Progressed |
DistantMetastasis |
54 |
LN+ |
ER- |
PR- |
G2 |
6 |
T3/T4 |
2 |
2 |
2.25 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100044 | NA |
Normal |
IBE |
NA |
ICR2 |
HER2+ |
400003296 |
NUH.BT031 |
DistantMetastasisFree |
5.63 |
DiseaseFree |
DistantMetastasisFree |
48 |
LN- |
ER+ |
PR+ |
G2 |
2 |
T1c |
5.63 |
5.63 |
5.63 |
NA |
NA |
NA |
0 |
invasive ductal carcinoma |
NA |
GSM1100045 | NA |
Normal |
IBE |
NA |
ICR3 |
HER2+ |
400003297 |
NUH.BT035 |
DistantMetastasisFree |
4.04 |
DiseaseFree |
DistantMetastasisFree |
46 |
LN- |
ER- |
PR- |
G2 |
1.5 |
T1c |
4.04 |
4.04 |
4.08 |
0 |
no |
no |
0 |
invasive ductal carcinoma |
none |
GSM1100046 | NA |
NA |
IBE |
NA |
ICR2 |
HER2- |
400003298 |
NUH.BT042 |
DistantMetastasisFree |
6 |
DiseaseFree |
DistantMetastasisFree |
53 |
LN- |
ER+ |
PR- |
G2 |
1.8 |
T1c |
6 |
6 |
6 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100047 | NA |
ClaudinLow |
IBD |
WID |
ICR2 |
HER2- |
400003299 |
NUH.BT046 |
DistantMetastasisFree |
5.79 |
DiseaseFree |
DistantMetastasisFree |
52 |
LN- |
ER+ |
PR+ |
G2 |
1.8 |
T1c |
5.79 |
5.79 |
5.79 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CMF |
GSM1100048 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2- |
400003300 |
NUH.BT047 |
DistantMetastasisFree |
5.83 |
DiseaseFree |
DistantMetastasisFree |
50 |
LN+ |
ER- |
PR+ |
G2 |
2.5 |
T2 |
5.83 |
5.83 |
5.83 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100049 | NA |
LumB |
IBD |
WID |
ICR2 |
HER2- |
400003301 |
NUH.BT049 |
DistantMetastasisFree |
5.75 |
DiseaseFree |
DistantMetastasisFree |
53 |
LN+ |
ER- |
PR+ |
G2 |
2.2 |
T2 |
5.75 |
5.75 |
5.92 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CMF |
GSM1100050 | NA |
Normal |
IBE |
NA |
ICR3 |
HER2+ |
400003302 |
NUH.BT054 |
DistantMetastasisFree |
5.58 |
DiseaseFree |
DistantMetastasisFree |
77 |
LN- |
ER+ |
PR- |
G2 |
3.5 |
T2 |
5.58 |
5.58 |
5.58 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100051 | NA |
Her2 |
IBD |
PID |
ICR2 |
HER2- |
400003303 |
NUH.BT055 |
DistantMetastasisFree |
6.33 |
DiseaseFree |
DistantMetastasisFree |
60 |
LN- |
ER+ |
PR+ |
G2 |
2 |
T1c |
6.33 |
6.33 |
6.33 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100052 | NA |
NA |
NA |
NA |
NA |
HER2+ |
400003304 |
NUH.BT061 |
NA |
NA |
NA |
NA |
51 |
LN+ |
ER+ |
PR- |
G2 |
2.5 |
T2 |
NA |
NA |
NA |
1 |
yes |
yes |
NA |
invasive ductal carcinoma |
Tam+ACx8;taxol |
GSM1100053 | NA |
Basal |
IBD |
WID |
ICR2 |
HER2- |
400003305 |
NUH.BT067 |
DistantMetastasisFree |
5 |
DiseaseFree |
DistantMetastasisFree |
69 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
5 |
5 |
5 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100054 | NA |
Her2 |
IBD |
WID |
ICR2 |
HER2+ |
400003306 |
NUH.BT068 |
DistantMetastasisFree |
5.25 |
DiseaseFree |
DistantMetastasisFree |
49 |
LN+ |
ER+ |
PR+ |
G2 |
2.3 |
T2 |
5.25 |
5.25 |
5.25 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CAFx6 cycles |
GSM1100055 | NA |
Her2 |
IBD |
PID |
ICR1 |
HER2- |
400003307 |
NUH.BT070 |
DistantMetastasis |
0.04 |
Recurred/Progressed |
DistantMetastasis |
48 |
LN- |
ER+ |
PR- |
G2 |
1.5 |
T1c |
0.04 |
0.04 |
3.08 |
1 |
no |
yes |
1 |
invasive lobular carcinoma |
anastrozole;taxol |
GSM1100056 | NA |
LumB |
IBD |
FID |
ICR4 |
HER2+ |
400003308 |
NUH.BT074 |
DistantMetastasisFree |
0.67 |
Recurred/Progressed |
DistantMetastasisFree |
75 |
LN+ |
ER- |
PR+ |
G2 |
4 |
T2 |
0.92 |
0.67 |
5.42 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100057 | NA |
Her2 |
IBD |
FID |
ICR2 |
HER2+ |
400003309 |
NUH.BT078 |
DistantMetastasis |
2.83 |
Recurred/Progressed |
DistantMetastasis |
67 |
LN- |
ER- |
PR- |
G2 |
2.5 |
T2 |
2.83 |
2.83 |
2.83 |
0 |
no |
no |
0 |
invasive ductal carcinoma |
none |
GSM1100058 | NA |
Her2 |
IBE |
FID |
ICR4 |
HER2- |
400003310 |
NUH.BT083 |
DistantMetastasisFree |
0.67 |
Recurred/Progressed |
DistantMetastasisFree |
55 |
LN- |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
1.25 |
0.67 |
4.58 |
0 |
no |
no |
0 |
invasive ductal carcinoma |
none |
GSM1100059 | NA |
Basal |
IBE |
PID |
ICR4 |
HER2- |
400003311 |
NUH.BT086 |
DistantMetastasisFree |
4.67 |
DiseaseFree |
DistantMetastasisFree |
35 |
LN- |
ER- |
PR+ |
G2 |
4 |
T2 |
4.67 |
4.67 |
4.67 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100060 | NA |
Basal |
IBE |
FID |
ICR4 |
HER2+ |
400003312 |
NUH.BT087 |
DistantMetastasisFree |
5.67 |
DiseaseFree |
DistantMetastasisFree |
46 |
LN+ |
ER+ |
PR+ |
G2 |
3 |
T2 |
5.67 |
5.67 |
5.67 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100061 | NA |
Basal |
IBE |
FID |
ICR4 |
HER2- |
400003313 |
NUH.BT088 |
DistantMetastasisFree |
4.67 |
DiseaseFree |
DistantMetastasisFree |
44 |
LN- |
ER+ |
PR+ |
G2 |
3.5 |
T2 |
4.67 |
4.67 |
4.67 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CMF |
GSM1100062 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
HER2- |
400003314 |
NUH.BT090 |
DistantMetastasisFree |
5.17 |
DiseaseFree |
DistantMetastasisFree |
40 |
LN+ |
ER+ |
PR+ |
G2 |
2.3 |
T2 |
5.17 |
5.17 |
5.17 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100063 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2+ |
400003315 |
NUH.BT093 |
DistantMetastasisFree |
4.75 |
DiseaseFree |
DistantMetastasisFree |
57 |
LN- |
ER+ |
PR+ |
G2 |
2.1 |
T2 |
4.75 |
4.75 |
4.75 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100064 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2- |
400003316 |
NUH.BT094 |
DistantMetastasisFree |
4.92 |
DiseaseFree |
DistantMetastasisFree |
55 |
LN+ |
ER+ |
PR+ |
G2 |
1.9 |
T1c |
4.92 |
4.92 |
4.92 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100065 | NA |
LumB |
IBD |
PID |
ICR2 |
HER2+ |
400003317 |
NUH.BT095 |
DistantMetastasisFree |
0.42 |
DiseaseFree |
DistantMetastasisFree |
44 |
LN+ |
ER+ |
PR+ |
G2 |
2.4 |
T2 |
0.42 |
0.42 |
0.42 |
0 |
no |
no |
0 |
invasive ductal carcinoma |
none |
GSM1100066 | NA |
LumB |
IBD |
WID |
ICR3 |
HER2+ |
400003318 |
NUH.BT096 |
DistantMetastasis |
1.67 |
Recurred/Progressed |
DistantMetastasis |
46 |
LN+ |
ER+ |
PR- |
G2 |
6 |
T3/T4 |
1.67 |
1.67 |
1.75 |
1 |
yes |
yes |
1 |
invasive ductal carcinoma |
Tam+CAFx2 cycles |
GSM1100067 | NA |
LumB |
IBD |
WID |
ICR3 |
HER2- |
400003319 |
NUH.BT097 |
DistantMetastasisFree |
4.5 |
DiseaseFree |
DistantMetastasisFree |
42 |
LN+ |
ER+ |
PR- |
G2 |
3 |
T2 |
4.5 |
4.5 |
4.5 |
NA |
NA |
NA |
0 |
invasive ductal carcinoma |
NA |
GSM1100068 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2- |
400003320 |
NUH.BT103 |
DistantMetastasisFree |
4.88 |
DiseaseFree |
DistantMetastasisFree |
46 |
LN- |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
4.88 |
4.88 |
4.88 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100069 | NA |
Her2 |
IBD |
PID |
ICR1 |
HER2- |
400003321 |
NUH.BT104 |
DistantMetastasisFree |
4.83 |
DiseaseFree |
DistantMetastasisFree |
73 |
LN+ |
ER+ |
PR+ |
G2 |
2 |
T1c |
4.83 |
4.83 |
4.92 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100070 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2- |
400003322 |
NUH.BT108 |
DistantMetastasisFree |
4 |
DiseaseFree |
DistantMetastasisFree |
46 |
LN+ |
ER- |
PR+ |
G2 |
4 |
T2 |
4 |
4 |
4.5 |
NA |
NA |
NA |
0 |
invasive ductal and lobular carcinoma |
NA |
GSM1100071 | NA |
NA |
NA |
NA |
NA |
HER2+ |
400003323 |
NUH.BT111 |
NA |
NA |
NA |
NA |
66 |
LN- |
ER+ |
PR+ |
G2 |
1.7 |
T1c |
NA |
NA |
0.08 |
NA |
NA |
NA |
0 |
invasive ductal carcinoma |
NA |
GSM1100072 | NA |
LumB |
IBD |
WID |
ICR1 |
HER2- |
400003324 |
NUH.BT113 |
DistantMetastasisFree |
5.58 |
DiseaseFree |
DistantMetastasisFree |
64 |
LN- |
ER+ |
PR+ |
G2 |
1.2 |
T1c |
5.58 |
5.58 |
5.58 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100073 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2- |
400003325 |
NUH.BT114 |
DistantMetastasisFree |
5.33 |
DiseaseFree |
DistantMetastasisFree |
49 |
LN- |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
5.33 |
5.33 |
5.33 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100074 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
HER2- |
400003326 |
NUH.BT119 |
DistantMetastasisFree |
5 |
DiseaseFree |
DistantMetastasisFree |
47 |
LN- |
ER+ |
PR+ |
G2 |
3.5 |
T2 |
5 |
5 |
5 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100075 | NA |
Basal |
IBD |
PID |
ICR1 |
HER2+ |
400003327 |
NUH.BT001 |
DistantMetastasisFree |
1.54 |
DiseaseFree |
DistantMetastasisFree |
34 |
LN- |
ER- |
PR- |
G3 |
4 |
T2 |
1.54 |
1.54 |
5.46 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100076 | NA |
Normal |
IBE |
NA |
ICR2 |
HER2- |
400003328 |
NUH.BT010 |
DistantMetastasisFree |
5.46 |
DiseaseFree |
DistantMetastasisFree |
45 |
LN- |
ER+ |
PR+ |
G1 |
1.5 |
T1c |
5.46 |
5.46 |
5.46 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen;goserelin |
GSM1100077 | NA |
LumA |
IBD |
WID |
ICR4 |
HER2+ |
400003329 |
NUH.BT100 |
DistantMetastasisFree |
4.46 |
DiseaseFree |
DistantMetastasisFree |
55 |
LN- |
ER+ |
PR+ |
G3 |
2 |
T1c |
4.46 |
4.46 |
4.46 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100078 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2- |
400003330 |
NUH.BT101 |
DistantMetastasisFree |
4.88 |
DiseaseFree |
DistantMetastasisFree |
47 |
LN+ |
ER+ |
PR+ |
G3 |
3.2 |
T2 |
4.88 |
4.88 |
4.88 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100079 | NA |
Basal |
IBD |
PID |
ICR1 |
HER2- |
400003331 |
NUH.BT102 |
DistantMetastasisFree |
0.13 |
DiseaseFree |
DistantMetastasisFree |
66 |
LN- |
ER+ |
PR+ |
G1 |
3.8 |
T2 |
NA |
0.13 |
0.13 |
1 |
yes |
no |
0 |
mucinous carcinoma |
tamoxifen |
GSM1100080 | NA |
LumA |
IBD |
PID |
ICR2 |
HER2+ |
400003332 |
NUH.BT107 |
DistantMetastasisFree |
1 |
DiseaseFree |
DistantMetastasisFree |
55 |
LN- |
ER- |
PR- |
G3 |
6 |
T3/T4 |
1 |
1 |
5 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100081 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2+ |
400003333 |
NUH.BT110 |
DistantMetastasisFree |
4 |
DiseaseFree |
DistantMetastasisFree |
52 |
LN+ |
ER- |
PR- |
G3 |
3.5 |
T2 |
4 |
4 |
4.33 |
1 |
no |
yes |
0 |
invasive lobular carcinoma |
ACx4 cycles |
GSM1100082 | NA |
Basal |
IBE |
PID |
ICR2 |
HER2+ |
400003334 |
NUH.BT112 |
DistantMetastasis |
2.04 |
Recurred/Progressed |
DistantMetastasis |
74 |
LN+ |
ER+ |
PR- |
G3 |
3 |
T2 |
2.04 |
2.04 |
2.25 |
1 |
yes |
no |
1 |
invasive ductal carcinoma |
tamoxifen |
GSM1100083 | NA |
Basal |
IBE |
PID |
ICR2 |
NA |
400003335 |
NUH.BT117 |
DistantMetastasisFree |
4 |
DiseaseFree |
DistantMetastasisFree |
44 |
LN+ |
ER- |
PR- |
G3 |
5 |
T2 |
4 |
4 |
4 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100084 | NA |
Her2 |
IBE |
FID |
ICR3 |
HER2+ |
400003336 |
NUH.BT012 |
DistantMetastasis |
3.96 |
Recurred/Progressed |
DistantMetastasis |
54 |
LN+ |
ER- |
PR- |
G3 |
2 |
T1c |
3.96 |
3.96 |
4.63 |
1 |
no |
yes |
1 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100085 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2+ |
400003337 |
NUH.BT120 |
DistantMetastasisFree |
5.25 |
DiseaseFree |
DistantMetastasisFree |
45 |
LN+ |
ER+ |
PR+ |
G3 |
2.5 |
T2 |
5.25 |
5.25 |
5.29 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
AC |
GSM1100086 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2+ |
400003338 |
NUH.BT013 |
DistantMetastasisFree |
1.96 |
DiseaseFree |
DistantMetastasisFree |
58 |
LN+ |
ER+ |
PR+ |
G3 |
3 |
T2 |
1.96 |
1.96 |
1.96 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100087 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
HER2+ |
400003339 |
NUH.BT015 |
DistantMetastasis |
0.001 |
Recurred/Progressed |
DistantMetastasis |
62 |
LN+ |
ER+ |
PR+ |
G3 |
2.5 |
T2 |
0 |
0 |
2.08 |
1 |
yes |
yes |
1 |
invasive ductal carcinoma |
Arimidex+CMFx2 cycles |
GSM1100088 | NA |
Her2 |
IBD |
PID |
ICR1 |
HER2+ |
400003340 |
NUH.BT016 |
DistantMetastasis |
0.88 |
Recurred/Progressed |
DistantMetastasis |
62 |
LN+ |
ER- |
PR- |
G3 |
3.5 |
T2 |
0.88 |
0.88 |
1 |
0 |
no |
no |
0 |
invasive ductal carcinoma |
none |
GSM1100089 | NA |
Normal |
IBE |
NA |
ICR3 |
HER2+ |
400003341 |
NUH.BT017 |
DistantMetastasisFree |
5.08 |
DiseaseFree |
DistantMetastasisFree |
64 |
LN- |
ER- |
PR- |
G3 |
3 |
T2 |
5.08 |
5.08 |
5.08 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100090 | NA |
Normal |
IBE |
NA |
ICR4 |
HER2+ |
400003342 |
NUH.BT002 |
DistantMetastasisFree |
4.83 |
DiseaseFree |
DistantMetastasisFree |
45 |
LN+ |
ER- |
PR- |
G3 |
2 |
T1c |
4.83 |
4.83 |
4.83 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100091 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2- |
400003343 |
NUH.BT020 |
DistantMetastasis |
1.96 |
Recurred/Progressed |
DistantMetastasis |
80 |
LN+ |
ER+ |
PR+ |
G3 |
4 |
T2 |
1.96 |
1.96 |
1.96 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100092 | NA |
LumA |
IBD |
FID |
ICR4 |
HER2- |
400003344 |
NUH.BT003 |
DistantMetastasisFree |
5.54 |
DiseaseFree |
DistantMetastasisFree |
41 |
LN- |
ER- |
PR- |
G3 |
4 |
T2 |
5.54 |
5.54 |
5.54 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100093 | NA |
LumB |
IBE |
PID |
ICR1 |
HER2+ |
400003345 |
NUH.BT033 |
DistantMetastasis |
0.13 |
Recurred/Progressed |
DistantMetastasis |
46 |
LN+ |
ER- |
PR- |
G3 |
2.2 |
T2 |
0.13 |
0.13 |
0.38 |
NA |
NA |
NA |
1 |
invasive ductal carcinoma |
NA |
GSM1100094 | NA |
LumA |
IBD |
FID |
ICR3 |
HER2+ |
400003346 |
NUH.BT034 |
DistantMetastasis |
1.29 |
Recurred/Progressed |
DistantMetastasis |
54 |
LN+ |
ER- |
PR- |
G3 |
3.5 |
T2 |
1.29 |
1.29 |
1.38 |
1 |
no |
yes |
1 |
invasive ductal carcinoma |
CAF |
GSM1100095 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2- |
400003347 |
NUH.BT036 |
DistantMetastasisFree |
3.13 |
DiseaseFree |
DistantMetastasisFree |
86 |
LN+ |
ER+ |
PR+ |
G1 |
2.1 |
T2 |
3.13 |
3.13 |
4.38 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100096 | NA |
ClaudinLow |
IBD |
FID |
ICR4 |
HER2- |
400003348 |
NUH.BT037 |
DistantMetastasis |
2.21 |
Recurred/Progressed |
DistantMetastasis |
29 |
LN+ |
ER+ |
PR+ |
G1 |
8 |
T3/T4 |
2.21 |
2.21 |
3.04 |
1 |
no |
yes |
1 |
invasive lobular carcinoma |
CAFx6 cycles |
GSM1100097 | NA |
LumB |
IBD |
PID |
ICR3 |
HER2+ |
400003349 |
NUH.BT038 |
DistantMetastasisFree |
4.38 |
DiseaseFree |
DistantMetastasisFree |
34 |
LN+ |
ER+ |
PR+ |
G3 |
3.5 |
T2 |
4.38 |
4.38 |
4.38 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx8 cycles; taxol |
GSM1100098 | NA |
LumB |
IBE |
PID |
ICR3 |
HER2- |
400003350 |
NUH.BT039 |
DistantMetastasisFree |
5.08 |
DiseaseFree |
DistantMetastasisFree |
48 |
LN+ |
ER- |
PR- |
G3 |
3 |
T2 |
5.08 |
5.08 |
5.08 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100099 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2- |
400003351 |
NUH.BT004 |
DistantMetastasisFree |
4.17 |
DiseaseFree |
DistantMetastasisFree |
42 |
LN- |
ER- |
PR- |
G3 |
2.2 |
T2 |
4.17 |
4.17 |
4.25 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
AC |
GSM1100100 | NA |
Her2 |
IBD |
WID |
ICR2 |
HER2- |
400003352 |
NUH.BT040 |
DistantMetastasisFree |
0.75 |
DiseaseFree |
DistantMetastasisFree |
48 |
LN- |
ER- |
PR- |
G3 |
3.5 |
T2 |
0.75 |
0.75 |
0.75 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100101 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2+ |
400003353 |
NUH.BT041 |
DistantMetastasisFree |
6.29 |
DiseaseFree |
DistantMetastasisFree |
52 |
LN+ |
ER+ |
PR+ |
G3 |
4.5 |
T2 |
6.29 |
6.29 |
6.29 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100102 | NA |
Normal |
IBE |
NA |
ICR1 |
HER2- |
400003354 |
NUH.BT043 |
DistantMetastasisFree |
5.58 |
DiseaseFree |
DistantMetastasisFree |
60 |
LN- |
ER+ |
PR+ |
G1 |
1.5 |
T1c |
5.58 |
5.58 |
5.79 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100103 | NA |
LumB |
IBE |
PID |
ICR1 |
HER2+ |
400003355 |
NUH.BT045 |
DistantMetastasis |
0.79 |
Recurred/Progressed |
DistantMetastasis |
51 |
LN+ |
ER- |
PR- |
G3 |
3 |
T2 |
0.79 |
0.79 |
1.46 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100104 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2+ |
400003356 |
NUH.BT048 |
DistantMetastasis |
2.29 |
Recurred/Progressed |
DistantMetastasis |
38 |
LN- |
ER+ |
PR- |
G3 |
3.6 |
T2 |
2.29 |
2.29 |
2.88 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100105 | NA |
LumA |
IBD |
FID |
ICR4 |
HER2+ |
400003357 |
NUH.BT005 |
DistantMetastasisFree |
4 |
DiseaseFree |
DistantMetastasisFree |
42 |
LN- |
ER- |
PR- |
G3 |
2.3 |
T2 |
4 |
4 |
4 |
NA |
NA |
NA |
0 |
invasive ductal carcinoma |
NA |
GSM1100106 | NA |
NA |
NA |
NA |
NA |
HER2- |
400003358 |
NUH.BT050 |
NA |
NA |
NA |
NA |
81 |
LN- |
ER+ |
PR+ |
G1 |
4 |
T2 |
NA |
NA |
NA |
1 |
yes |
no |
NA |
papillary carcinoma |
tamoxifen |
GSM1100107 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2- |
400003359 |
NUH.BT051 |
DistantMetastasisFree |
3.5 |
DiseaseFree |
DistantMetastasisFree |
77 |
LN- |
ER+ |
PR+ |
G1 |
4 |
T2 |
3.5 |
3.5 |
4.33 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100108 | NA |
Normal |
IBE |
NA |
ICR3 |
HER2- |
400003360 |
NUH.BT052 |
DistantMetastasisFree |
1.17 |
DiseaseFree |
DistantMetastasisFree |
42 |
LN- |
ER- |
PR- |
G3 |
2 |
T1c |
1.17 |
1.17 |
6.5 |
0 |
no |
no |
0 |
medullary carcinoma |
none |
GSM1100109 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2- |
400003361 |
NUH.BT053 |
DistantMetastasisFree |
5.88 |
DiseaseFree |
DistantMetastasisFree |
61 |
LN+ |
ER+ |
PR- |
G3 |
2.5 |
T2 |
5.88 |
5.88 |
5.88 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CMF |
GSM1100110 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2+ |
400003362 |
NUH.BT056 |
DistantMetastasisFree |
5.71 |
DiseaseFree |
DistantMetastasisFree |
48 |
LN- |
ER- |
PR- |
G3 |
3.2 |
T2 |
5.71 |
5.71 |
5.71 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100111 | NA |
Basal |
IBD |
FID |
ICR3 |
HER2+ |
400003363 |
NUH.BT059 |
DistantMetastasisFree |
5.83 |
DiseaseFree |
DistantMetastasisFree |
61 |
LN+ |
ER- |
PR- |
G3 |
1.5 |
T1c |
5.83 |
5.83 |
5.83 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAFx6 cycles |
GSM1100112 | NA |
LumA |
IBD |
FID |
ICR3 |
HER2- |
400003364 |
NUH.BT006 |
DistantMetastasisFree |
6.17 |
DiseaseFree |
DistantMetastasisFree |
36 |
LN- |
ER+ |
PR+ |
G3 |
2.5 |
T2 |
6.17 |
6.17 |
6.17 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100113 | NA |
Basal |
IBE |
PID |
ICR1 |
HER2+ |
400003365 |
NUH.BT060 |
DistantMetastasisFree |
1.33 |
Recurred/Progressed |
DistantMetastasisFree |
51 |
LN- |
ER- |
PR- |
G3 |
2.7 |
T2 |
1.92 |
1.33 |
5.58 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100114 | NA |
LumB |
IBE |
WID |
ICR3 |
HER2- |
400003366 |
NUH.BT062 |
DistantMetastasisFree |
5.83 |
DiseaseFree |
DistantMetastasisFree |
46 |
LN- |
ER- |
PR- |
G3 |
2.5 |
T2 |
5.83 |
5.83 |
5.83 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100115 | NA |
Her2 |
IBE |
WID |
ICR4 |
HER2+ |
400003367 |
NUH.BT063 |
DistantMetastasisFree |
5.83 |
DiseaseFree |
DistantMetastasisFree |
48 |
LN- |
ER- |
PR- |
G3 |
3.5 |
T2 |
5.83 |
5.83 |
5.83 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100116 | NA |
Basal |
IBE |
PID |
ICR2 |
HER2- |
400003368 |
NUH.BT064 |
DistantMetastasisFree |
5.79 |
DiseaseFree |
DistantMetastasisFree |
51 |
LN- |
ER+ |
PR- |
G3 |
1.8 |
T1c |
5.79 |
5.79 |
5.79 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100117 | NA |
Her2 |
IBD |
PID |
ICR2 |
HER2+ |
400003369 |
NUH.BT065 |
DistantMetastasisFree |
5.88 |
DiseaseFree |
DistantMetastasisFree |
47 |
LN- |
ER- |
PR- |
G3 |
2.1 |
T2 |
5.88 |
5.88 |
5.88 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
ACx4 cycles |
GSM1100118 | NA |
LumA |
IBD |
PID |
ICR2 |
HER2+ |
400003370 |
NUH.BT066 |
DistantMetastasisFree |
5.92 |
DiseaseFree |
DistantMetastasisFree |
58 |
LN+ |
ER+ |
PR+ |
G3 |
5.1 |
T3/T4 |
5.92 |
5.92 |
5.92 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100119 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2+ |
400003371 |
NUH.BT007 |
DistantMetastasisFree |
5.58 |
DiseaseFree |
DistantMetastasisFree |
38 |
LN- |
ER+ |
PR+ |
G3 |
3.8 |
T2 |
5.58 |
5.58 |
5.58 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100120 | NA |
Basal |
IBE |
PID |
ICR1 |
HER2- |
400003372 |
NUH.BT071 |
DistantMetastasisFree |
4.54 |
DiseaseFree |
DistantMetastasisFree |
47 |
LN+ |
ER+ |
PR+ |
G3 |
3 |
T2 |
4.54 |
4.54 |
4.54 |
1 |
no |
yes |
0 |
invasive ductal carcinoma |
CAF |
GSM1100121 | NA |
Basal |
IBE |
FID |
ICR4 |
HER2+ |
400003373 |
NUH.BT072 |
DistantMetastasisFree |
5.21 |
DiseaseFree |
DistantMetastasisFree |
64 |
LN- |
ER+ |
PR+ |
G3 |
5 |
T2 |
5.21 |
5.21 |
5.21 |
1 |
yes |
no |
0 |
medullary carcinoma |
tamoxifen |
GSM1100122 | NA |
Her2 |
IBE |
WID |
ICR2 |
HER2+ |
400003374 |
NUH.BT073 |
DistantMetastasis |
3.83 |
Recurred/Progressed |
DistantMetastasis |
50 |
LN+ |
ER- |
PR+ |
G3 |
1.6 |
T1c |
3.83 |
3.83 |
5.75 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100123 | NA |
Her2 |
IBD |
FID |
ICR3 |
HER2- |
400003375 |
NUH.BT076 |
DistantMetastasisFree |
5.17 |
DiseaseFree |
DistantMetastasisFree |
52 |
LN- |
ER+ |
PR+ |
G1 |
2 |
T1c |
5.17 |
5.17 |
5.17 |
1 |
yes |
no |
0 |
invasive lobular carcinoma |
tamoxifen |
GSM1100124 | NA |
LumB |
IBE |
WID |
ICR3 |
HER2+ |
400003376 |
NUH.BT077 |
DistantMetastasisFree |
4.92 |
DiseaseFree |
DistantMetastasisFree |
67 |
LN+ |
ER+ |
PR- |
G3 |
2.5 |
T2 |
4.92 |
4.92 |
4.92 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100125 | NA |
Normal |
IBE |
NA |
ICR3 |
HER2+ |
400003377 |
NUH.BT008 |
DistantMetastasis |
2 |
Recurred/Progressed |
DistantMetastasis |
38 |
LN+ |
ER+ |
PR+ |
G3 |
4 |
T2 |
2 |
2 |
2 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+AC |
GSM1100126 | NA |
LumB |
IBE |
PID |
ICR3 |
HER2- |
400003378 |
NUH.BT082 |
DistantMetastasisFree |
0.83 |
DiseaseFree |
DistantMetastasisFree |
84 |
LN- |
ER+ |
PR+ |
G3 |
2.8 |
T2 |
0.83 |
0.83 |
0.83 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100127 | NA |
Normal |
IBE |
NA |
ICR2 |
NA |
400003379 |
NUH.BT084 |
DistantMetastasisFree |
4.67 |
DiseaseFree |
DistantMetastasisFree |
55 |
LN- |
NA |
NA |
G1 |
2.5 |
T2 |
4.67 |
4.67 |
4.67 |
0 |
no |
no |
0 |
invasive ductal carcinoma and papillary carcinoma |
none |
GSM1100128 | NA |
ClaudinLow |
IBD |
WID |
ICR2 |
HER2- |
400003380 |
NUH.BT089 |
DistantMetastasisFree |
2.67 |
DiseaseFree |
DistantMetastasisFree |
43 |
LN+ |
ER+ |
PR+ |
G1 |
2.4 |
T2 |
2.67 |
2.67 |
2.67 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+ACx4 cycles |
GSM1100129 | NA |
LumB |
IBD |
WID |
ICR2 |
HER2- |
400003381 |
NUH.BT091 |
DistantMetastasisFree |
4.38 |
DiseaseFree |
DistantMetastasisFree |
62 |
LN- |
ER+ |
PR+ |
G3 |
2 |
T1c |
4.38 |
4.38 |
4.38 |
1 |
yes |
no |
0 |
invasive ductal carcinoma |
tamoxifen |
GSM1100130 | NA |
Her2 |
IBD |
PID |
ICR1 |
HER2- |
400003382 |
NUH.BT092 |
DistantMetastasisFree |
4.83 |
DiseaseFree |
DistantMetastasisFree |
59 |
LN+ |
ER+ |
PR+ |
G1 |
6 |
T3/T4 |
4.83 |
4.83 |
4.83 |
NA |
NA |
NA |
0 |
invasive ductal carcinoma |
NA |
GSM1100131 | NA |
LumB |
IBD |
PID |
ICR1 |
NA |
400003383 |
NUH.BT099 |
DistantMetastasisFree |
4.33 |
DiseaseFree |
DistantMetastasisFree |
53 |
LN+ |
ER+ |
PR+ |
G3 |
3.5 |
T2 |
4.33 |
4.33 |
4.33 |
1 |
yes |
yes |
0 |
invasive ductal carcinoma |
Tam+CMFx6 cycles |
GSM1100132 | NA |
Her2 |
IBD |
PID |
ICR1 |
HER2+ |
400003384 |
95_1279 |
DistantMetastasis |
3.05 |
NA |
DistantMetastasis |
63 |
LN- |
ER+ |
NA |
G2 |
3 |
T2 |
NA |
3.05 |
3.449315068 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100133 | NA |
Her2 |
IBE |
PID |
ICR3 |
HER2+ |
400003385 |
95_9670 |
DistantMetastasis |
1.39 |
NA |
DistantMetastasis |
47 |
LN- |
ER+ |
PR+ |
G3 |
2.8 |
T2 |
NA |
1.39 |
2.126027397 |
1 |
yes |
yes |
1 |
NA |
CMFx6; Tamoxifen |
GSM1100134 | NA |
Her2 |
IBE |
FID |
ICR3 |
HER2+ |
400003386 |
96_6784 |
DistantMetastasis |
0.65 |
NA |
DistantMetastasis |
59 |
LN- |
ER- |
PR- |
G3 |
2.5 |
T2 |
NA |
0.65 |
3.079452055 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100135 | NA |
LumB |
IBE |
PID |
ICR2 |
HER2- |
400003387 |
96_8645 |
DistantMetastasis |
4.18 |
NA |
DistantMetastasis |
66 |
LN- |
ER- |
PR- |
G3 |
2.1 |
T2 |
NA |
4.18 |
4.194520548 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100136 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2- |
400003388 |
97_4970 |
DistantMetastasis |
4.51 |
NA |
DistantMetastasis |
68 |
LN- |
ER+ |
PR+ |
G3 |
1.7 |
T1c |
NA |
4.51 |
6.17260274 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100137 | NA |
Her2 |
IBD |
FID |
ICR4 |
HER2+ |
400003389 |
97_2461 |
DistantMetastasis |
0.25 |
NA |
DistantMetastasis |
57 |
LN- |
ER+ |
PR+ |
NA |
8.5 |
T3/T4 |
NA |
0.25 |
5.035616438 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100138 | NA |
LumB |
IBE |
PID |
ICR1 |
HER2- |
400003390 |
97_6230 |
DistantMetastasis |
1.35 |
NA |
DistantMetastasis |
38 |
LN- |
ER+ |
PR- |
G3 |
3.2 |
T2 |
NA |
1.35 |
2.753424658 |
1 |
yes |
yes |
1 |
NA |
ECx4; Tamoxifen |
GSM1100139 | NA |
LumB |
IBE |
PID |
ICR1 |
HER2- |
400003391 |
97_10495 |
DistantMetastasis |
2.21 |
NA |
DistantMetastasis |
63 |
LN- |
ER+ |
PR+ |
G3 |
4.6 |
T2 |
NA |
2.21 |
4.928767123 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100140 | NA |
Basal |
IBE |
PID |
ICR2 |
HER2- |
400003392 |
98_1467 |
DistantMetastasis |
3.8 |
NA |
DistantMetastasis |
73 |
LN- |
ER- |
PR- |
G3 |
3.4 |
T2 |
NA |
3.8 |
4.621917808 |
1 |
no |
yes |
1 |
NA |
ACx3/CMFx1 |
GSM1100141 | NA |
LumB |
IBE |
PID |
ICR1 |
HER2+ |
400003393 |
00_4773 |
DistantMetastasis |
0.76 |
NA |
DistantMetastasis |
70 |
LN- |
ER+ |
PR+ |
G3 |
3.5 |
T2 |
NA |
0.76 |
0.991780822 |
1 |
yes |
no |
1 |
NA |
Tamoxifen |
GSM1100142 | NA |
LumA |
IBD |
WID |
ICR3 |
HER2- |
400003394 |
97_3659 |
DistantMetastasisFree |
2.18 |
NA |
DistantMetastasisFree |
46 |
LN- |
ER+ |
PR- |
G1 |
1 |
T1b |
NA |
2.18 |
2.189041096 |
1 |
yes |
yes |
0 |
NA |
Tamoxifen+Zoledronic acid |
GSM1100143 | NA |
LumB |
IBD |
PID |
ICR2 |
HER2- |
400003395 |
95_5655 |
DistantMetastasis |
2.42 |
NA |
DistantMetastasis |
36 |
LN- |
ER- |
PR- |
G2 |
1.3 |
T1c |
NA |
2.42 |
7.079452055 |
1 |
yes |
yes |
0 |
NA |
Tamoxifen+Zoledronic acid |
GSM1100144 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2- |
400003396 |
96_1378 |
DistantMetastasis |
6.15 |
NA |
DistantMetastasis |
54 |
LN- |
ER+ |
PR- |
G1 |
5.5 |
T3/T4 |
NA |
6.15 |
8.021917808 |
1 |
no |
yes |
0 |
NA |
ACx4 |
GSM1100145 | NA |
LumB |
IBD |
WID |
ICR3 |
HER2- |
400003397 |
97_2927 |
DistantMetastasis |
3.65 |
NA |
DistantMetastasis |
60 |
LN- |
ER+ |
PR+ |
G3 |
4 |
T2 |
NA |
3.65 |
6.750684932 |
1 |
yes |
yes |
0 |
NA |
CMFx2; Tamoxifen |
GSM1100146 | NA |
LumB |
IBD |
WID |
ICR2 |
HER2+ |
400003398 |
98_478 |
DistantMetastasis |
3.3 |
NA |
DistantMetastasis |
72 |
LN- |
ER+ |
PR+ |
G3 |
3.7 |
T2 |
NA |
3.3 |
5.164383562 |
1 |
yes |
no |
0 |
NA |
Arimidex/Tamoxifen |
GSM1100147 | NA |
LumB |
IBE |
FID |
ICR4 |
HER2- |
400003399 |
95_5029 |
DistantMetastasisFree |
7.82 |
NA |
DistantMetastasisFree |
54 |
LN- |
ER- |
PR- |
G2 |
1 |
T1b |
NA |
7.82 |
7.821917808 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100148 | NA |
Her2 |
IBE |
PID |
ICR3 |
HER2+ |
400003400 |
94_14421 |
DistantMetastasisFree |
7.85 |
NA |
DistantMetastasisFree |
48 |
LN- |
ER+ |
NA |
G2 |
1.2 |
T1c |
NA |
7.85 |
7.854794521 |
1 |
yes |
yes |
0 |
NA |
Tamoxifen+Zoledronic acid |
GSM1100149 | NA |
LumB |
IBD |
WID |
ICR3 |
HER2- |
400003401 |
95_6413 |
DistantMetastasisFree |
7.31 |
NA |
DistantMetastasisFree |
55 |
LN- |
ER+ |
PR+ |
G3 |
1.8 |
T1c |
NA |
7.31 |
7.306849315 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100150 | NA |
Her2 |
IBD |
PID |
ICR1 |
HER2+ |
400003402 |
95_11893 |
DistantMetastasisFree |
7.57 |
NA |
DistantMetastasisFree |
81 |
LN- |
ER+ |
PR- |
G2 |
2 |
T1c |
NA |
7.57 |
7.57260274 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100151 | NA |
Normal |
IBE |
NA |
ICR2 |
HER2+ |
400003403 |
96_4793 |
DistantMetastasisFree |
6.02 |
NA |
DistantMetastasisFree |
52 |
LN- |
ER- |
PR- |
G2 |
2 |
T1c |
NA |
6.02 |
6.019178082 |
1 |
yes |
yes |
0 |
NA |
ACx4; Tamoxifen |
GSM1100152 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2+ |
400003404 |
97_938 |
DistantMetastasisFree |
6.18 |
NA |
DistantMetastasisFree |
77 |
LN- |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
NA |
6.18 |
6.175342466 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100153 | NA |
LumB |
IBD |
WID |
ICR3 |
HER2+ |
400003405 |
96_3800 |
DistantMetastasisFree |
6.65 |
NA |
DistantMetastasisFree |
70 |
LN- |
ER+ |
PR- |
G2 |
3.5 |
T2 |
NA |
6.65 |
6.652054795 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100154 | NA |
Basal |
IBE |
WID |
ICR3 |
HER2- |
400003406 |
96_2614 |
DistantMetastasisFree |
6.61 |
NA |
DistantMetastasisFree |
67 |
LN- |
ER- |
PR- |
G3 |
4 |
T2 |
NA |
6.61 |
6.61369863 |
1 |
yes |
yes |
0 |
NA |
ACx6; Tamoxifen |
GSM1100155 | NA |
Her2 |
IBE |
WID |
ICR3 |
HER2+ |
400003407 |
96_3132 |
DistantMetastasisFree |
6.13 |
NA |
DistantMetastasisFree |
62 |
LN- |
ER+ |
PR+ |
G3 |
2.7 |
T2 |
NA |
6.13 |
6.128767123 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100156 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2- |
400003408 |
96_8234 |
DistantMetastasisFree |
5.94 |
NA |
DistantMetastasisFree |
66 |
LN- |
ER+ |
PR+ |
G1 |
2.7 |
T2 |
NA |
5.94 |
5.936986301 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100157 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2+ |
400003409 |
96_14641 |
DistantMetastasisFree |
3.12 |
NA |
DistantMetastasisFree |
57 |
LN- |
ER+ |
PR- |
G1 |
2 |
T1c |
NA |
3.12 |
3.115068493 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100158 | NA |
LumB |
IBE |
WID |
ICR3 |
NA |
400003410 |
96_9210 |
DistantMetastasisFree |
2.57 |
NA |
DistantMetastasisFree |
46 |
LN- |
NA |
NA |
G3 |
3.2 |
T2 |
NA |
2.57 |
2.57260274 |
1 |
yes |
yes |
0 |
NA |
CMFx6; Tamoxifen |
GSM1100159 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
HER2- |
400003411 |
96_12695 |
DistantMetastasisFree |
6.19 |
NA |
DistantMetastasisFree |
73 |
LN- |
ER- |
PR- |
NA |
3.8 |
T2 |
NA |
6.19 |
6.18630137 |
NA |
NA |
NA |
0 |
NA |
NA |
GSM1100160 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2- |
400003412 |
97_1564 |
DistantMetastasisFree |
6.69 |
NA |
DistantMetastasisFree |
42 |
LN- |
ER+ |
PR+ |
G2 |
1.4 |
T1c |
NA |
6.69 |
6.693150685 |
1 |
no |
yes |
0 |
NA |
CMFx6 |
GSM1100161 | NA |
LumB |
IBE |
FID |
ICR4 |
HER2- |
400003413 |
97_3340 |
DistantMetastasisFree |
5.52 |
NA |
DistantMetastasisFree |
53 |
LN- |
ER+ |
PR+ |
G3 |
1.9 |
T1c |
NA |
5.52 |
5.523287671 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100162 | NA |
LumA |
IBD |
PID |
ICR1 |
HER2- |
400003414 |
97_5410 |
DistantMetastasisFree |
5.11 |
NA |
DistantMetastasisFree |
60 |
LN- |
ER+ |
PR+ |
G3 |
2 |
T1c |
NA |
5.11 |
5.109589041 |
1 |
yes |
yes |
0 |
NA |
ACx4; Arimidex/Tamoxifen |
GSM1100163 | NA |
Basal |
IBE |
WID |
ICR3 |
HER2- |
400003415 |
97_7954 |
DistantMetastasisFree |
5.57 |
NA |
DistantMetastasisFree |
61 |
LN- |
ER- |
PR- |
G3 |
1.4 |
T1c |
NA |
5.57 |
5.567123288 |
1 |
yes |
yes |
0 |
NA |
CMFx6; Arimidex/Tamoxifen |
GSM1100164 | NA |
Her2 |
IBE |
FID |
ICR3 |
NA |
400003416 |
97_10321 |
DistantMetastasisFree |
6.26 |
NA |
DistantMetastasisFree |
59 |
LN- |
ER- |
PR- |
G3 |
4.5 |
T2 |
NA |
6.26 |
6.257534247 |
1 |
no |
yes |
0 |
NA |
ACx4 |
GSM1100165 | NA |
LumB |
IBD |
PID |
ICR1 |
HER2- |
400003417 |
97_10569 |
DistantMetastasisFree |
5.13 |
NA |
DistantMetastasisFree |
70 |
LN- |
ER+ |
PR- |
G2 |
2 |
T1c |
NA |
5.13 |
5.134246575 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100166 | NA |
LumA |
IBD |
PID |
ICR2 |
HER2- |
400003418 |
97_9201 |
DistantMetastasisFree |
4.64 |
NA |
DistantMetastasisFree |
45 |
LN- |
ER+ |
PR+ |
G2 |
2 |
T1c |
NA |
4.64 |
4.643835616 |
1 |
no |
yes |
0 |
NA |
CMFx6 |
GSM1100167 | NA |
Basal |
IBE |
PID |
ICR2 |
HER2+ |
400003419 |
98_176 |
DistantMetastasisFree |
5.01 |
NA |
DistantMetastasisFree |
48 |
LN- |
ER- |
PR- |
G3 |
6 |
T3/T4 |
NA |
5.01 |
5.008219178 |
1 |
no |
yes |
0 |
NA |
CMFx6 |
GSM1100168 | NA |
LumA |
IBD |
PID |
ICR2 |
HER2+ |
400003420 |
97_12101 |
DistantMetastasisFree |
4.56 |
NA |
DistantMetastasisFree |
45 |
LN- |
ER+ |
PR+ |
G2 |
3 |
T2 |
NA |
4.56 |
4.561643836 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100169 | NA |
Basal |
IBE |
FID |
ICR4 |
HER2- |
400003421 |
98_301 |
DistantMetastasisFree |
4.96 |
NA |
DistantMetastasisFree |
46 |
LN- |
ER- |
PR- |
G3 |
2.7 |
T2 |
NA |
4.96 |
4.95890411 |
1 |
yes |
yes |
0 |
NA |
CMFx6; Tamoxifen |
GSM1100170 | NA |
LumA |
IBD |
WID |
ICR2 |
HER2+ |
400003422 |
98_8377 |
DistantMetastasisFree |
3.93 |
NA |
DistantMetastasisFree |
56 |
LN- |
ER+ |
PR+ |
G1 |
3 |
T2 |
NA |
3.93 |
3.926027397 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100171 | NA |
LumB |
IBD |
FID |
ICR4 |
HER2- |
400003423 |
98_2095 |
DistantMetastasisFree |
4.51 |
NA |
DistantMetastasisFree |
72 |
LN- |
ER+ |
PR- |
G2 |
2 |
T1c |
NA |
4.51 |
4.509589041 |
1 |
yes |
no |
0 |
NA |
Tamoxifen |
GSM1100172 | NA |
ClaudinLow |
IBD |
FID |
ICR3 |
HER2- |
400003424 |
01_1620 |
DistantMetastasisFree |
1.66 |
NA |
DistantMetastasisFree |
50 |
LN- |
ER- |
PR- |
G3 |
2.9 |
T2 |
NA |
1.66 |
1.660273973 |
1 |
no |
yes |
0 |
NA |
CMFx6 |
GSM1100173 | NA |
ClaudinLow |
IBD |
FID |
ICR3 |
NA |
400003425 |
OXFU_369 |
DistantMetastasis |
7.15 |
Recurred/Progressed |
DistantMetastasis |
67 |
LN- |
ER- |
NA |
NA |
1 |
T1b |
7.15 |
7.151 |
NA |
0 |
no |
no |
NA |
NA |
none |
GSM1100174 | NA |
ClaudinLow |
IBD |
FID |
ICR3 |
NA |
400003426 |
OXFU_410 |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasisFree |
37 |
LN- |
ER- |
NA |
G2 |
2.3 |
T2 |
10.61 |
10.614 |
NA |
0 |
no |
no |
NA |
NA |
none |
GSM1100175 | NA |
ClaudinLow |
IBD |
FID |
ICR3 |
NA |
400003427 |
OXFU_554 |
DistantMetastasisFree |
9.42 |
DiseaseFree |
DistantMetastasisFree |
43 |
LN- |
ER+ |
NA |
G1 |
2.1 |
T2 |
9.42 |
9.419 |
NA |
0 |
no |
no |
NA |
NA |
none |
Name | ||
---|---|---|
All Samples | Default | View |
ER Status | View | |
Histology Differentiation Grade | View | |
Immune Benefit Status | View | |
Immunological Constant of Rejection | View | |
Lymph Node Status | View | |
Molecular Subtype | View | |
Pathology T Stage | View | |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
ER Status | |
Histology Differentiation Grade | |
Immune Benefit Status | |
Immunological Constant of Rejection | |
Lymph Node Status | |
Molecular Subtype | |
Pathology T Stage |